News

News

NEW GMP-certificate!

We were successfully audited on 4th of April at our new site in Grambach and have received our  N E W  GMP certificate from the Austrian authorities!

 

Please find our new certificate here!

Change Notification

Dear customers and valued business partners!

Over the past 25 years piCHEM has been supplying its clients with synthetic peptides, synthetic peptide/protein conjugates and/or peptide based substances and drug products for clinical trial and as commercial products.

We herewith inform that the address of the company has changed per December 30, 2016 to

piCHEM Forschungs- und Entwicklungs GmbH

Parkring 3

8074 Raaba-Grambach

AUSTRIA

GPS: 47.02, 15.50


Reason of the change

piCHEM wants to provide all clients with the optimum of support to assist their business and ideas.

The new site will offer increased security, capacity and flexibility to best serve our clients' demands for high quality peptides and peptide/protein conjugates.


Change evaluation

This change has been reported to the Austrian Authorities. Layout, construction and processes of the new facility have been designed in accordance with applicable laws and jurisdiction. Layout, construction and processes of the new facility were designed in accordance with applicabel laws and jurisdiction.

The new productin site will enable us to operate at a high level of current GMP quality standards for the manufacturing of active ingredients. For final manufacturing steps cleanrooms in class C will be available.

Currently used processes and equipment will be transferred to the new facility. Transfer of products and equipment will be performed under controlled conditions. To provide continuously high quality products the trained personnel engaged in the current sites will be employed in the new site.

As soon as the Manufacturer's Authorization for the new site will be available piCHEM will provide the documents to its customers.

Please contact us, if you need more information!

 

FDA - Certificate of Registration

piCHEM announces the successful registration with the U.S. Food and Drug Administration for the statutory filing period.

 

DUNS Number: 303575690

 

Find our FDA certificate here!

French Ministry approves piCHEM as R&D Subcontractor

French Ministry of Research approves

piCHEM as R & D Subcontractor

 

piCHEM has successfully renewed its status as an approved company for research and development projects by the French Ministry of Research. This approval enables private companies subject to corporate tax in France to claim R&D tax credits for work subcontracted to piCHEM.

Read more: French Ministry approves piCHEM as R&D Subcontractor

BetaCure

BetaCure (2014-2018) http://betacure.eu/about/partners/pichem

Personalized diagnosis and treatment of hyperinsulinemic hypoglycaemia caused by beta-cell pathology

Read more: BetaCure